SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-287569
Filing Date
2021-09-30
Accepted
2021-09-30 10:47:02
Documents
12
Period of Report
2021-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d238646d8ka.htm   iXBRL 8-K/A 27378
  Complete submission text file 0001193125-21-287569.txt   154996

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tpst-20210712.xsd EX-101.SCH 2517
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpst-20210712_lab.xml EX-101.LAB 18694
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpst-20210712_pre.xml EX-101.PRE 11672
5 EXTRACTED XBRL INSTANCE DOCUMENT d238646d8ka_htm.xml XML 4365
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35890 | Film No.: 211294092
SIC: 2834 Pharmaceutical Preparations